Assurance Healthcare Statistics
Total Valuation
FRA:7IQ has a market cap or net worth of EUR 7.88 million. The enterprise value is 6.82 million.
| Market Cap | 7.88M |
| Enterprise Value | 6.82M |
Important Dates
The last earnings date was Tuesday, November 18, 2025.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 263.32M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.82% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 46.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.64 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 6.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.01 |
| EV / Sales | 17.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.08 |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.72 |
| Quick Ratio | 3.68 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | -62.71 |
Financial Efficiency
Return on equity (ROE) is -18.67% and return on invested capital (ROIC) is -10.75%.
| Return on Equity (ROE) | -18.67% |
| Return on Assets (ROA) | -9.86% |
| Return on Invested Capital (ROIC) | -10.75% |
| Return on Capital Employed (ROCE) | -19.20% |
| Revenue Per Employee | 54,522 |
| Profits Per Employee | -108,106 |
| Employee Count | 7 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,348 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -96.88% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 46.53 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:7IQ had revenue of EUR 381,656 and -756,741 in losses. Loss per share was -0.00.
| Revenue | 381,656 |
| Gross Profit | -186,000 |
| Operating Income | -845,393 |
| Pretax Income | -892,154 |
| Net Income | -756,741 |
| EBITDA | -817,635 |
| EBIT | -845,393 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.12 million in cash and 125,048 in debt, giving a net cash position of 996,376.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 125,048 |
| Net Cash | 996,376 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.32M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.22M |
Cash Flow
In the last 12 months, operating cash flow was -664,754 and capital expenditures -297,397, giving a free cash flow of -962,151.
| Operating Cash Flow | -664,754 |
| Capital Expenditures | -297,397 |
| Free Cash Flow | -962,151 |
| FCF Per Share | n/a |
Margins
Gross margin is -48.73%, with operating and profit margins of -221.51% and -198.28%.
| Gross Margin | -48.73% |
| Operating Margin | -221.51% |
| Pretax Margin | -233.76% |
| Profit Margin | -198.28% |
| EBITDA Margin | -214.23% |
| EBIT Margin | -221.51% |
| FCF Margin | n/a |
Dividends & Yields
FRA:7IQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.82% |
| Shareholder Yield | -10.82% |
| Earnings Yield | -9.61% |
| FCF Yield | -12.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:7IQ has an Altman Z-Score of 7.58 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.58 |
| Piotroski F-Score | 2 |